Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
Public ClinicalTrials.gov record NCT00002109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT/ddI or AZT/ddC) Anti-Retroviral Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To confirm results from a previous study in which the combination of thymopentin plus zidovudine ( AZT ), an antiretroviral agent, slowed disease progression in HIV-infected asymptomatic patients. To evaluate the efficacy and safety of thymopentin in HIV-infected asymptomatic patients receiving either monotherapy with AZT, didanosine ( ddI ), or stavudine ( d4T ), or combination antiretroviral therapy with AZT / ddI or AZT / zalcitabine ( ddC ).
Study identification
- NCT ID
- NCT00002109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fisher Med Group | Phoenix | Arizona | 85013 | — |
| Ctr for Special Immunology | Irvine | California | 92718 | — |
| Beer Med Group | Los Angeles | California | 90036 | — |
| Gottlieb Med Group | Pasadena | California | 90112 | — |
| AIDS Community Research Consortium | Redwood City | California | 94063 | — |
| HIV Research Group | San Diego | California | 92102 | — |
| Conant Med Group | San Francisco | California | 94115 | — |
| Kaiser Permanente Med Ctr | San Francisco | California | 94115 | — |
| Pacific Oaks Med Group | Sherman Oaks | California | 91403 | — |
| Harbor - UCLA Med Ctr | Torrance | California | 90502 | — |
| Dr Gary Blick | Greenwich | Connecticut | 06830 | — |
| Dr Larry Bruni | Washington D.C. | District of Columbia | 20003 | — |
| Novum Inc | Washington D.C. | District of Columbia | 20037 | — |
| Community Research Initiative | Coral Gables | Florida | 33146 | — |
| Ctr for Special Immunology | Fort Lauderdale | Florida | 33316 | — |
| Stratogen of Ft Lauderdale | Fort Lauderdale | Florida | 33334 | — |
| Stratogen of South Florida | Miami Beach | Florida | 33140 | — |
| Infectious Disease Research Institute Inc | Tampa | Florida | 33614 | — |
| Saint Joseph's Hosp / Infectious Disease Rsch Institute | Tampa | Florida | 33614 | — |
| West Paces Clinical Research Inc | Atlanta | Georgia | 30327 | — |
| Northwestern Univ Med Ctr | Chicago | Illinois | 60611 | — |
| Rush Presbyterian - Saint Luke's Med Ctr | Chicago | Illinois | 60612 | — |
| Ctr for Special Immunology | Chicago | Illinois | 60657 | — |
| Infectious Diseases Research Clinic / Indiana Univ Hosp | Indianapolis | Indiana | 46202 | — |
| Univ of Kansas School of Medicine | Wichita | Kansas | 67214 | — |
| CRI of New England | Brookline | Massachusetts | 02445 | — |
| Kansas City AIDS Research Consortium | Kansas City | Missouri | 641082792 | — |
| Systemic Mycoses Pathogen Study Group / Wash Univ Sch of Med | St Louis | Missouri | 63108 | — |
| Lovelace Scientific Resource | Albuquerque | New Mexico | 87108 | — |
| Dr David DiPietro | New York | New York | 10001 | — |
| Ctr for Special Immunology | New York | New York | 10010 | — |
| Dr Howard A Grossman | New York | New York | 10014 | — |
| Dr Patrick Hennessey | New York | New York | 10016 | — |
| New York Hosp - Cornell Med Ctr | New York | New York | 10021 | — |
| SUNY / Health Sciences Ctr at Stony Brook | Stony Brook | New York | 117948153 | — |
| Van Etten Hosp / Bronx Municipal Hosp Ctr | The Bronx | New York | 10461 | — |
| Cleveland Clinic | Cleveland | Ohio | 44106 | — |
| Associates Med and Mental Health | Tulsa | Oklahoma | 741141325 | — |
| Dr Joel Godbey | Portland | Oregon | 97232 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| Graduate Hosp | Philadelphia | Pennsylvania | 19146 | — |
| Novum Inc | Pittsburgh | Pennsylvania | 15206 | — |
| Central Texas Med Foundation | Austin | Texas | 78751 | — |
| Dr Christopher McNulty | Dallas | Texas | 75219 | — |
| Nelson-Tebedo Community Clinic | Dallas | Texas | 75219 | — |
| Houston Clinical Research Network | Houston | Texas | 77006 | — |
| Hampton Roads Med Specialists | Hampton | Virginia | 23666 | — |
| Novum Inc | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002109 live on ClinicalTrials.gov.